LFWD

$7.56

Post-MarketAs of Mar 17, 8:00 PM UTC

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$7.56
Potential Upside
5%
Whystock Fair Value$7.94
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.53M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.14
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-127.95%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.89

Recent News

GuruFocus.com
Mar 17, 2026

Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead Of Earnings

This article first appeared on GuruFocus. Lifeward Ltd (NASDAQ:LFWD) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $7.86 million, and the earnings are expected to come in at -$1.08 per share.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Nov 14, 2025

Lifeward Ltd (LFWD) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges

Lifeward Ltd (LFWD) reports modest revenue growth, strategic advancements, and financial hurdles in its Q3 2025 earnings call.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Nov 14, 2025

Lifeward (LFWD) Q3 2025 Earnings Call Transcript

William Mark Grant: Thank you, Almog. Since joining Lifeward Ltd. in June, I have completed a sober and comprehensive assessment of the business, starting with our strategic direction down to our commercial model and operations.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Nov 14, 2025

Market Sentiment Around Loss-Making Lifeward Ltd. (NASDAQ:LFWD)

We feel now is a pretty good time to analyse Lifeward Ltd.'s ( NASDAQ:LFWD ) business as it appears the company may be...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Associated Press Finance
Nov 14, 2025

Lifeward: Q3 Earnings Snapshot

MARLBOROUGH, Mass. AP) — Lifeward Ltd. (LFWD) on Friday reported a loss of $3.2 million in its third quarter. The Marlborough, Massachusetts-based company said it had a loss of 20 cents per share.

BEARISH
Negative press. News cycle fixated on risk factors or misses.